BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17220427)

  • 1. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
    Li JX; Becker GL; Traynor JR; Gong ZH; France CP
    J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
    Ko MC; Johnson MD; Butelman ER; Willmont KJ; Mosberg HI; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1113-20. PubMed ID: 10565831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta opioid antagonist effects of buprenorphine in rhesus monkeys.
    Negus SS; Bidlack JM; Mello NK; Furness MS; Rice KC; Brandt MR
    Behav Pharmacol; 2002 Nov; 13(7):557-70. PubMed ID: 12409994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
    Ko MC; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):378-85. PubMed ID: 10087027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.
    Butelman ER; Negus SS; Ai Y; de Costa BR; Woods JH
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1269-76. PubMed ID: 8263790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys.
    Negus SS
    Psychopharmacology (Berl); 2004 Nov; 176(2):204-13. PubMed ID: 15112031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
    Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
    Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.
    Paronis CA; Bergman J
    J Pharmacol Exp Ther; 2011 Feb; 336(2):488-95. PubMed ID: 21051498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
    J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
    Pitts RC; Allen RM; Walker EA; Dykstra LA
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
    Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
    Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.